Karpecki P - Search Results

1

Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).

Gaddie IB, Donnenfeld ED, Karpecki P, Vollmer P, Berdy GJ, Peterson JD, Simmons B, Edell ARP, Whitson WE, Ciolino JB, Baba SN, Holdbrook M, Trevejo J, Meyer J, Yeu E; Saturn-2 Study Group. Gaddie IB, et al. Among authors: karpecki p. Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5. Ophthalmology. 2023. PMID: 37285925 Free article. Clinical Trial.

2

An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye.

Ousler G 3rd, Devries DK, Karpecki PM, Ciolino JB. Ousler G 3rd, et al. Clin Ophthalmol. 2015 Feb 5;9:235-43. doi: 10.2147/OPTH.S75297. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25709384 Free PMC article.

3

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.

Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP; OPUS-2 Investigators. Tauber J, et al. Among authors: karpecki p. Ophthalmology. 2015 Dec;122(12):2423-31. doi: 10.1016/j.ophtha.2015.08.001. Epub 2015 Sep 11. Ophthalmology. 2015. PMID: 26365210 Free article. Clinical Trial.

4

Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.

Donnenfeld ED, Karpecki PM, Majmudar PA, Nichols KK, Raychaudhuri A, Roy M, Semba CP. Donnenfeld ED, et al. Among authors: karpecki pm. Cornea. 2016 Jun;35(6):741-8. doi: 10.1097/ICO.0000000000000803. Cornea. 2016. PMID: 27055211 Free PMC article. Clinical Trial.

5

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).

Holland EJ, Luchs J, Karpecki PM, Nichols KK, Jackson MA, Sall K, Tauber J, Roy M, Raychaudhuri A, Shojaei A. Holland EJ, et al. Ophthalmology. 2017 Jan;124(1):53-60. doi: 10.1016/j.ophtha.2016.09.025. Epub 2016 Oct 27. Ophthalmology. 2017. PMID: 28079022 Free article. Clinical Trial.

6

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye.

Torkildsen G, Brujic M, Cooper MS, Karpecki P, Majmudar P, Trattler W, Reis M, Ciolino JB. Torkildsen G, et al. Among authors: karpecki p. Clin Ophthalmol. 2017 Oct 19;11:1883-1889. doi: 10.2147/OPTH.S144369. eCollection 2017. Clin Ophthalmol. 2017. PMID: 29089744 Free PMC article.

7

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.

Nichols KK, Donnenfeld ED, Karpecki PM, Hovanesian JA, Raychaudhuri A, Shojaei A, Zhang S. Nichols KK, et al. Eur J Ophthalmol. 2019 Jul;29(4):394-401. doi: 10.1177/1120672118791936. Epub 2018 Aug 16. Eur J Ophthalmol. 2019. PMID: 30112930 Free PMC article. Clinical Trial.

8

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.

Pepose JS, Hartman PJ, DuBiner HB, Abrams MA, Smyth-Medina RJ, Moroi SE, Meyer AR, Sooch MP, Jaber RM, Charizanis K, Klapman SA, Amin AT, Yousif JE, Lazar ES, Karpecki PM, Slonim CB, McDonald MB. Pepose JS, et al. Among authors: karpecki pm. Clin Ophthalmol. 2021 Jan 8;15:79-91. doi: 10.2147/OPTH.S278169. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33447013 Free PMC article.

9

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.

Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P. Sheppard J, et al. Among authors: karpecki p. Clin Ophthalmol. 2021 Jan 12;15:129-140. doi: 10.2147/OPTH.S279364. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33469259 Free PMC article. Clinical Trial.

10

Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial.

Clark D, Cavanagh B, Shields AL, Karpecki P, Sheppard J, Brady TC. Clark D, et al. Among authors: karpecki p. Am J Ophthalmol. 2021 Oct;230:60-67. doi: 10.1016/j.ajo.2021.04.023. Epub 2021 May 1. Am J Ophthalmol. 2021. PMID: 33945820 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page